The EU health ministers on 16 June approved a common stance on a piece of legislation that accompanies the Biotech Act regulation — Biotech Act I directive.
The directive tweaks two directives on modified micro-organisms (GMMs) and the processing of organs. The aim — to make them more innovation-friendly, reduce administrative burdens and improve cross-border cooperation in organ transplantation, in a desperate attempt to catch up with biotech frontrunners — such as the US and China.
